Related Experiment Videos

[Monocyte functional activity and nonspecific antiviral cellular resistance in a group at high risk for developing

Terapevticheskii Arkhiv
|January 1, 1992
PubMed

Insights

Patients at risk for pneumonia show reduced monocyte function and antiviral resistance. This suggests monitoring immune cell activity and considering immunomodulatory and antiviral therapies for pneumonia prevention.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cellular Biology

Background:

  • Pneumonia risk is a significant public health concern.
  • Understanding cellular mechanisms underlying pneumonia susceptibility is crucial.
  • Monocyte function and antiviral resistance play roles in host defense.

Purpose of the Study:

  • To investigate the relationship between monocyte functional activity, antiviral cellular resistance, and intracellular viremia in patients at risk for pneumonia.
  • To compare these parameters with those in healthy individuals.

Main Methods:

  • Functional activity of monocytes was assessed in 132 patients at risk for pneumonia.
  • Antiviral cellular resistance and intracellular viremia status in monocytes and lymphocytes were evaluated.
  • A control group of 46 healthy men was included for comparison.

Main Results:

  • Patients prone to pneumonia exhibited abnormal mononuclear phagocyte function.
  • A decrease in antiviral cellular resistance was observed in at-risk patients.
  • Intracellular viremia status correlated with immune cell function.

Conclusions:

  • Proneness to pneumonia is linked to impaired monocyte function and reduced antiviral defense.
  • Monitoring monocyte activity and viremia in immune cells is necessary.
  • Immunomodulatory and antiviral therapies may be advisable for pneumonia prevention.

Related Concept Videos